Zobrazeno 1 - 10
of 38
pro vyhledávání: '"David Kaminetzky"'
Autor:
Daniel Freeman, Catherine Diefenbach, Linda Lam, Tri Le, Jason Alexandre, Bruce Raphael, Michael Grossbard, David Kaminetzky, Jia Ruan, Pratip K. Chattopadhyay
Publikováno v:
Cell Reports, Vol 43, Iss 8, Pp 114605- (2024)
Summary: Immune cells express an incredible variety of proteins; by measuring combinations of these, cell types influencing disease can be precisely identified. We developed terraFlow, a platform that defines cell subsets exhaustively by combinatoria
Externí odkaz:
https://doaj.org/article/4552513b2fa146f4b556f6d1f3966949
Autor:
Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, Dan Vogl, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Paul Richardson, Noa Biran, David Siegel, Philip Vlummens, Chantal Doyen, Thierry Facon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc Raab, David Dingli, Sascha Tuchman, Frenzel Laurent, Ravi Vij, Gary Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri Parker, Robert Frank Cornell, Karlin Lionel, Sylvain Choquet, Jagannath Sundar
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Selinexor is an oral, selective nuclear export inhibitor. STORM was a phase 2b, single-arm, open-label, multicenter trial of selinexor with low dose dexamethasone in patients with penta-exposed relapsed/refractory multiple myeloma
Externí odkaz:
https://doaj.org/article/ad0d07b841e64c82afc2fcdee19751cf
Autor:
David Kaminetzky, Kenneth B Hymes
Publikováno v:
Biologics: Targets & Therapy, Vol 2008, Iss Issue 4, Pp 717-724 (2008)
David Kaminetzky1, Kenneth B Hymes21Division of Hematology/Oncology, New York University School of Medicine, New York, USA; 2New York University Cancer Institute, New York, USAAbstract: Cutaneous T-cell lymphoma/mycosis fungoides (CTCL/MF) is a rare
Externí odkaz:
https://doaj.org/article/7f82a9298b1741aeb1c6a723b6e91f15
Autor:
Ola Landgren, Gareth J. Morgan, Suzanne Lentzsch, Ruben Niesvizky, Sundar Jagannath, Faith E. Davies, Ying Taur, Ran Reshef, Christian Gordillo, Marc J. Braunstein, David Kaminetzky, Ajai Chari, Deepu Madduri, Roger N. Pearse, Adriana Rossi, Benjamin Diamond, Andriy Derkach, Francesco Maura, Carlyn Tan, Hani Hassoun, Alexander M. Lesokhin, Urvi A. Shah, Sham Mailankody, Sydney X. Lu, Neha Korde, Eric L. Smith, Dhwani Patel, Cara A. Rosenbaum, Joshua Richter, Malin Hultcrantz
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53454f0abd907aba2e1ad9eb141d8e39
https://doi.org/10.1158/2643-3230.22542939
https://doi.org/10.1158/2643-3230.22542939
Autor:
Ola Landgren, Gareth J. Morgan, Suzanne Lentzsch, Ruben Niesvizky, Sundar Jagannath, Faith E. Davies, Ying Taur, Ran Reshef, Christian Gordillo, Marc J. Braunstein, David Kaminetzky, Ajai Chari, Deepu Madduri, Roger N. Pearse, Adriana Rossi, Benjamin Diamond, Andriy Derkach, Francesco Maura, Carlyn Tan, Hani Hassoun, Alexander M. Lesokhin, Urvi A. Shah, Sham Mailankody, Sydney X. Lu, Neha Korde, Eric L. Smith, Dhwani Patel, Cara A. Rosenbaum, Joshua Richter, Malin Hultcrantz
Patients with multiple myeloma have a compromised immune system, due to both the disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID-19. Here, we report outcomes and risk factors for serious disease in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc094855f250432258fa025fb0580e50
https://doi.org/10.1158/2643-3230.c.6550092
https://doi.org/10.1158/2643-3230.c.6550092
Autor:
Hussein Ghamlouch, Marc Braunstein, Yubao Wang, Ben Diamond, James H. Stoeckle, Louis Williams, David Kaminetzky, Faith E. Davies, Cody Ashby, Eileen M Boyle, Gareth J. Morgan, Michael A Bauer, Kylee H Maclachlan, Francesco Maura, Benedetto Bruno, Patrick Blaney, Even H. Rustad, Ola Landgren, Brian A Walker
Publikováno v:
Seminars in Cell & Developmental Biology. 123:115-123
Analysis of the genetic basis for multiple myeloma (MM) has informed many of our current concepts of the biology that underlies disease initiation and progression. Studying these events in further detail is predicted to deliver important insights int
Autor:
Jessica Caro, Marc Braunstein, Louis Williams, Benedetto Bruno, David Kaminetzky, Ariel Siegel, Beatrice Razzo, Serge Alfandari, Gareth J. Morgan, Faith E. Davies, Eileen M. Boyle
Publikováno v:
Leukemia
The role of infection and chronic inflammation in plasma cell disorders (PCD) has been well-described. Despite not being a diagnostic criterion, infection is a common complication of most PCD and represents a significant cause of morbidity and mortal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b15f88c5c38479ce87fd2202c0bf711e
http://hdl.handle.net/2318/1874819
http://hdl.handle.net/2318/1874819
Autor:
Jason Alexandre, Tri Le, Bruce Raphael, Daniel Freeman, Pratip K. Chattopadhyay, Linda Lam, Michael L. Grossbard, David Kaminetzky, Jia Ruan, Catherine Diefenbach
The incredible variety of proteins associated with immune responses presents a major challenge in immune monitoring. When combinations of these proteins are measured, cell types that influence disease can be precisely identified. Here, we introduce T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3014b015fdd05c1913ddf9799d58f63
https://doi.org/10.1101/2021.09.10.21263388
https://doi.org/10.1101/2021.09.10.21263388
Autor:
Sharon Shacham, Jatin P. Shah, Robert F. Cornell, Ajay K. Nooka, Noa Biran, Paul G. Richardson, Mohamad Mohty, Terri L. Parker, Frenzel Laurent, Lingling Li, Monika Engelhardt, David Kaminetzky, Nathalie Meuleman, Thierry Facon, Jagannath Sundar, Joshua Richter, Gabriel Tremblay, Chantal Doyen, David S. Siegel, Martin Schreder, Philip Vlummens, Maria Gavriatopoulou, Michel Delforge, Marc S. Raab, Katja Weisel, Klaus Podar, Luciano J. Costa, Karlin Lionel, Dan T. Vogl, Philippe Moreau, Ravi Vij, David Dingli, Sascha A. Tuchman, Sylvain Choquet, Meletios-Athanasios Dimopoulos, Janis L. Breeze, Gary J. Schiller, James E. Hoffman, Michael Kauffman, Moshe Yair Levy, Patrick Daniele, Ajaj Chari
Publikováno v:
BMC Cancer
BMC CANCER
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC CANCER
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Background Selinexor is an oral, selective nuclear export inhibitor. STORM was a phase 2b, single-arm, open-label, multicenter trial of selinexor with low dose dexamethasone in patients with penta-exposed relapsed/refractory multiple myeloma (RRMM) t
Autor:
Tibor Moskovits, Akiko Koide, Judith D. Goldberg, Shella Saint-Fleur Lominy, Bruce Raphael, Catherine Diefenbach, Jessica Caro, Jun Choi, Sara A Thannickal, David Kaminetzky, Maxim Kreditor, Kenneth B. Hymes, Kenneth A. Stapleford, Michael L. Grossbard, Shohei Koide
Publikováno v:
medRxiv
Patients with hematologic malignancies are a high priority for SARS-CoV-2 vaccination, yet the benefit they will derive is uncertain. We investigated the humoral response to vaccination in 53 non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), or CLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b8b62e9137fb1c6c7bd089c6258f49
https://doi.org/10.1101/2021.06.02.21257804
https://doi.org/10.1101/2021.06.02.21257804